Cargando…
Imaging protein aggregates in the serum and cerebrospinal fluid in Parkinson’s disease
Aggregation of α-synuclein plays a key role in the development of Parkinson’s disease. Soluble aggregates are present not only within human brain but also the CSF and blood. Characterizing the aggregates present in these biofluids may provide insights into disease mechanisms and also have potential...
Autores principales: | Lobanova, Evgeniia, Whiten, Daniel, Ruggeri, Francesco S, Taylor, Christopher G, Kouli, Antonina, Xia, Zengjie, Emin, Derya, Zhang, Yu P, Lam, Jeff Y L, Williams-Gray, Caroline H, Klenerman, David |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Oxford University Press
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9014748/ https://www.ncbi.nlm.nih.gov/pubmed/34410317 http://dx.doi.org/10.1093/brain/awab306 |
Ejemplares similares
-
Imaging Protein
Aggregates in Parkinson’s Disease
Serum Using Aptamer-Assisted Single-Molecule Pull-Down
por: Zhang, Yu P., et al.
Publicado: (2023) -
Small soluble α-synuclein aggregates are the toxic species in Parkinson’s disease
por: Emin, Derya, et al.
Publicado: (2022) -
An antibody scanning method for the detection of α-synuclein oligomers in the serum of Parkinson's disease patients
por: Kulenkampff, Klara, et al.
Publicado: (2022) -
Soluble amyloid beta-containing aggregates are present throughout the brain at early stages of Alzheimer’s disease
por: Sideris, Dimitrios I, et al.
Publicado: (2021) -
Age-Related Adaptive Immune Changes in Parkinson’s Disease
por: Kouli, Antonina, et al.
Publicado: (2022)